Neogen (NEOG)
(Delayed Data from NSDQ)
$15.60 USD
-1.21 (-7.20%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $15.59 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum C VGM
Neogen (NEOG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$17.50 | $17.50 | $17.50 | 4.10% |
Price Target
Only one analyst offered a short-term price target of $17.50 for Neogen. This represents an increase of 4.1% from the last closing price of $16.81.
Analyst Price Targets (1 )
Broker Rating
Neogen currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | Piper Sandler | David M Westenberg | Hold | Hold |
7/15/2024 | William Blair | Brandon Vazquez | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 2 |
Average Target Price | $17.50 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 50 of 252 |
Current Quarter EPS Est: | 0.10 |
NEOG FAQs
Neogen Corporation (NEOG) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Neogen Corporation (NEOG) is $17.50. The current on short-term price targets is based on 2 reports.
The forecasts for Neogen Corporation (NEOG) range from a low of $17.5 to a high of $17.5. The average price target represents a increase of $12.18 from the last closing price of $15.60.
The current UPSIDE for Neogen Corporation (NEOG) is 12.18%
Only one analyst offered a short-term price target of $17.50 for Neogen. This represents an increase of 4.1% from the last closing price of $16.81.